Drybench Patent.

Patent and exclusivity dates in 2033 for NDAs on FDA's Paragraph IV list, as FDA lists them

Each patent and exclusivity date in 2033 that FDA's Orange Book lists, as captured on 14 October 2026, for the 607 NDAs that FDA's Paragraph IV list names, as captured on 17 October 2026, and whose Orange Book capture lists a patent or exclusivity. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026
Paragraph IV list captured: 17 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers only NDAs that FDA's Paragraph IV list names and that have Orange Book listings. It does not cover other NDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

FDA's Paragraph IV list names no patent number, so it does not say which of the patents on this page an applicant certified against.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed patent expiry (402)

2 Jan 2033 · NDA 205103 · ASPIRIN; OMEPRAZOLE
US 9,987,231, use patent
patent.txt lines 5,204, 5,206
Flags
use code U-2324
Product numbers
001, 002
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,195,168, product patent
patent.txt line 14,344
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,675,258, use patent
patent.txt line 14,347
Flags
use code U-2938
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,554,102, product patent
patent.txt line 14,354
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,591,922, product patent
patent.txt line 14,359
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,901,173, product patent
patent.txt line 14,363
Flags
product
Product numbers
001
11 Jan 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,132,107, product patent
patent.txt line 14,366
Flags
product
Product numbers
001
14 Jan 2033 · NDA 202123 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US 10,857,102, product patent
patent.txt line 2,774
Flags
product
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 10,717,764, use patent
patent.txt line 12,515
Flags
use code U-3215
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 11,667,673, use patent
patent.txt line 12,524
Flags
use code U-3742
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,531
Flags
substance product use code U-2350
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,532
Flags
substance product use code U-2533
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,533
Flags
substance product use code U-2534
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,534
Flags
substance product use code U-3213
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,535
Flags
substance product use code U-3386
Product numbers
001
18 Jan 2033 · NDA 211192 · IVOSIDENIB
US 9,850,277, substance and product and use patent
patent.txt line 12,536
Flags
substance product use code U-3742
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,149,829, use patent
patent.txt line 5,761
Flags
use code U-2477
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,149,829, use patent
patent.txt line 5,762
Flags
use code U-3006
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,449,176, use patent
patent.txt line 5,766
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,610,510, use patent
patent.txt line 5,767
Flags
use code U-2805
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,610,510, use patent
patent.txt line 5,768
Flags
use code U-3009
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,945,988, use patent
patent.txt line 5,772
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,980,770, use patent
patent.txt line 5,773
Flags
use code U-3106
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 10,980,770, use patent
patent.txt line 5,774
Flags
use code U-3107
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,285,129, use patent
patent.txt line 5,778
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,285,129, use patent
patent.txt line 5,779
Flags
use code U-3343
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,633,377, use patent
patent.txt line 5,781
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,633,377, use patent
patent.txt line 5,782
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,826,339, use patent
patent.txt line 5,787
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,826,339, use patent
patent.txt line 5,788
Flags
use code U-3343
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,833,130, use patent
patent.txt line 5,789
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,833,130, use patent
patent.txt line 5,790
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,850,229, use patent
patent.txt line 5,791
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,850,229, use patent
patent.txt line 5,792
Flags
use code U-3343
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,918,557, use patent
patent.txt line 5,795
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 11,918,557, use patent
patent.txt line 5,796
Flags
use code U-3865
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 12,201,604, use patent
patent.txt line 5,798
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 12,201,604, use patent
patent.txt line 5,799
Flags
use code U-3865
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,060,995, use patent
patent.txt line 5,800
Flags
use code U-1710
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,539,234, use patent
patent.txt line 5,801
Flags
use code U-1934
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,539,234, use patent
patent.txt line 5,802
Flags
use code U-3004
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,549,913, use patent
patent.txt line 5,803
Flags
use code U-1486
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US 9,855,241, use patent
patent.txt line 5,806
Flags
use code U-2149
Product numbers
001
25 Jan 2033 · NDA 205677 · TASIMELTEON
US RE46604, use patent
patent.txt line 5,807
Flags
use code U-2147
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 10,149,829, use patent
patent.txt line 15,836
Flags
use code U-3006
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 10,610,510, use patent
patent.txt line 15,839
Flags
use code U-3009
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 10,980,770, use patent
patent.txt line 15,842
Flags
use code U-3106
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,285,129, use patent
patent.txt line 15,846
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,633,377, use patent
patent.txt line 15,848
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,826,339, use patent
patent.txt line 15,852
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,833,130, use patent
patent.txt line 15,853
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,850,229, use patent
patent.txt line 15,854
Flags
use code U-3342
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 11,918,557, use patent
patent.txt line 15,856
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 12,201,604, use patent
patent.txt line 15,858
Flags
use code U-3003
Product numbers
001
25 Jan 2033 · NDA 214517 · TASIMELTEON
US 9,539,234, use patent
patent.txt line 15,860
Flags
use code U-3004
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,166,205, product patent
patent.txt line 4,455
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,166,206, product patent
patent.txt line 4,456
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,695,303, product patent
patent.txt line 4,457
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 10,729,667, product patent
patent.txt line 4,458
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 8,778,365, product patent
patent.txt line 4,459
Flags
product
Product numbers
001
31 Jan 2033 · NDA 204286 · NAFTIFINE HYDROCHLORIDE
US 9,161,914, use patent
patent.txt line 4,460
Flags
use code U-540
Product numbers
001
7 Feb 2033 · NDA 211964 · VILOXAZINE HYDROCHLORIDE
US 9,358,204, product patent
patent.txt lines 13,295, 13,301, 13,307
Flags
product
Product numbers
001, 002, 003
7 Feb 2033 · NDA 211964 · VILOXAZINE HYDROCHLORIDE
US 9,603,853, use patent
patent.txt lines 13,296, 13,302, 13,308
Flags
use code U-727
Product numbers
001, 002, 003
8 Feb 2033 · NDA 213535 · RISDIPLAM
US 9,586,955, substance and product patent
patent.txt line 15,085
Flags
substance product
Product numbers
001
8 Feb 2033 · NDA 219285 · RISDIPLAM
US 9,586,955, substance and product patent
patent.txt line 21,576
Flags
substance product
Product numbers
001
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,089,489, product and use patent
patent.txt line 10,778
Flags
product use code U-1382
Product numbers
001
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,375,404, product and use patent
patent.txt line 10,779
Flags
product use code U-1382
Product numbers
001
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,526,703, product and use patent
patent.txt line 10,780
Flags
product use code U-1382
Product numbers
001
18 Feb 2033 · NDA 209661 · DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
US 9,937,132, product and use patent
patent.txt line 10,781
Flags
product use code U-1382
Product numbers
001
25 Feb 2033 · NDA 212728 · RIMEGEPANT SULFATE
US 8,759,372, substance and product patent
patent.txt line 14,411
Flags
substance product
Product numbers
001
27 Feb 2033 · NDA 022325 · AMIODARONE HYDROCHLORIDE
US 9,493,582, product patent
patent.txt lines 1,696, 1,702
Flags
product
Product numbers
002, 003
27 Feb 2033 · NDA 202714 · CARFILZOMIB
US 9,493,582, product patent
patent.txt lines 3,143, 3,153, 3,163
Flags
product
Product numbers
001, 002, 003
27 Feb 2033 · NDA 205596 · POSACONAZOLE
US 9,493,582, product patent
patent.txt line 5,694
Flags
product
Product numbers
001
27 Feb 2033 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 9,493,582, product patent
patent.txt line 7,061
Flags
product
Product numbers
001
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 10,272,046, product and use patent
patent.txt lines 7,492, 7,525
Flags
product use code U-2531
Product numbers
001, 002
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 10,272,046, product and use patent
patent.txt line 7,558
Flags
product use code U-2967
Product numbers
003
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 10,272,046, product and use patent
patent.txt lines 7,591, 7,619
Flags
product use code U-3605
Product numbers
004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 11,147,770, product and use patent
patent.txt lines 7,496, 7,529, 7,562
Flags
product use code U-3339
Product numbers
001, 002, 003
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 11,147,770, product and use patent
patent.txt lines 7,595, 7,623
Flags
product use code U-3604
Product numbers
004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 11,752,106, product and use patent
patent.txt lines 7,500, 7,533, 7,566, 7,599, 7,627
Flags
product use code U-3697
Product numbers
001, 002, 003, 004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 12,214,083, product and use patent
patent.txt lines 7,502, 7,535
Flags
product use code U-4126
Product numbers
001, 002
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 12,214,083, product and use patent
patent.txt line 7,568
Flags
product use code U-4128
Product numbers
003
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 12,214,083, product and use patent
patent.txt lines 7,601, 7,629
Flags
product use code U-4127
Product numbers
004, 005
27 Feb 2033 · NDA 207925 · IVACAFTOR
US 8,883,206, product patent
patent.txt lines 7,520, 7,553, 7,586, 7,615, 7,643
Flags
product
Product numbers
001, 002, 003, 004, 005
28 Feb 2033 · NDA 209940 · LETERMOVIR
US 10,603,384, product patent
patent.txt lines 11,066, 11,068
Flags
product
Product numbers
001, 002
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 10,004,717, product and use patent
patent.txt line 11,311
Flags
product use code U-2398
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 10,543,192, product patent
patent.txt line 11,313
Flags
product
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 10,548,875, substance and product and use patent
patent.txt line 11,314
Flags
substance product use code U-2398
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 8,859,610, product and use patent
patent.txt line 11,316
Flags
product use code U-2398
Product numbers
001
28 Feb 2033 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 9,259,414, use patent
patent.txt line 11,317
Flags
use code U-2398
Product numbers
001
5 Mar 2033 · NDA 202107 · MIFEPRISTONE
US 10,500,216, use patent
patent.txt line 2,764
Flags
use code U-1643
Product numbers
001
5 Mar 2033 · NDA 205858 · IDELALISIB
US 10,730,879, substance and product patent
patent.txt lines 5,988, 5,992
Flags
substance product
Product numbers
001, 002
5 Mar 2033 · NDA 205858 · IDELALISIB
US 8,865,730, substance and product and use patent
patent.txt lines 5,989, 5,993
Flags
substance product use code U-1615
Product numbers
001, 002
5 Mar 2033 · NDA 210868 · LORLATINIB
US 8,680,111, substance and product patent
patent.txt lines 12,263, 12,268
Flags
substance product
Product numbers
001, 002
5 Mar 2033 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 8,785,500, use patent
patent.txt line 12,659
Flags
use code U-2502
Product numbers
001
5 Mar 2033 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 8,785,500, use patent
patent.txt line 12,660
Flags
use code U-4112
Product numbers
001
6 Mar 2033 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,555,001, product and use patent
patent.txt lines 7,989, 8,008
Flags
product use code U-1967
Product numbers
001, 002
6 Mar 2033 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,555,001, product and use patent
patent.txt lines 7,990, 8,009
Flags
product use code U-1968
Product numbers
001, 002
9 Mar 2033 · NDA 204958 · CANGRELOR
US 8,680,052, use patent
patent.txt line 5,183
Flags
use code U-2979
Product numbers
001
13 Mar 2033 · NDA 205103 · ASPIRIN; OMEPRAZOLE
US 9,539,214, use patent
patent.txt lines 5,203, 5,205
Flags
use code U-1902
Product numbers
001, 002
13 Mar 2033 · NDA 215206 · ATOGEPANT
US 9,850,246, substance patent
patent.txt lines 16,566, 16,573, 16,579
Flags
substance
Product numbers
001, 002, 003
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 10,188,632, product patent
patent.txt lines 6,846, 6,860
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,007,179, product patent
patent.txt lines 6,847, 6,861
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,090,291, product patent
patent.txt lines 6,848, 6,862
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,160,792, product patent
patent.txt lines 6,849, 6,863
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,229,627, product patent
patent.txt lines 6,850, 6,864
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,311,516, product patent
patent.txt lines 6,851, 6,865
Flags
product
Product numbers
001, 002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 11,484,527, use patent
patent.txt line 6,866
Flags
use code U-3475
Product numbers
002
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 12,097,187, use patent
patent.txt line 6,852
Flags
use code U-3475
Product numbers
001
14 Mar 2033 · NDA 206940 · ELUXADOLINE
US 9,675,587, product patent
patent.txt lines 6,857, 6,871
Flags
product
Product numbers
001, 002
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 10,213,400, use patent
patent.txt line 490
Flags
use code U-2499
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 10,864,181, use patent
patent.txt line 492
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 494
Flags
use code U-3323
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 495
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 11,986,446, use patent
patent.txt line 496
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 8,772,306, use patent
patent.txt line 498
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 9,050,302, use patent
patent.txt line 500
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 021196 · SODIUM OXYBATE
US 9,486,426, use patent
patent.txt line 502
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 10,052,385, use patent
patent.txt line 8,299
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 10,052,385, use patent
patent.txt line 8,300
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,000,021, use patent
patent.txt line 8,313
Flags
use code U-1542
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,034,908, use patent
patent.txt line 8,314
Flags
use code U-1542
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,144,568, use patent
patent.txt line 8,315
Flags
use code U-1542
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,887, use patent
patent.txt line 8,321
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,887, use patent
patent.txt line 8,322
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,579,384, use patent
patent.txt line 8,323
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,579,384, use patent
patent.txt line 8,324
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,397, use patent
patent.txt line 8,325
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,397, use patent
patent.txt line 8,326
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,398, use patent
patent.txt line 8,327
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,399, use patent
patent.txt line 8,328
Flags
use code U-1971
Product numbers
001
15 Mar 2033 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,597,399, use patent
patent.txt line 8,329
Flags
use code U-1972
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 10,568,855, use patent
patent.txt line 8,547
Flags
use code U-1
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 11,337,989, use patent
patent.txt line 8,548
Flags
use code U-1
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 11,439,610, substance and product patent
patent.txt line 8,549
Flags
substance product
Product numbers
001
15 Mar 2033 · NDA 208352 · CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE
US 11,992,472, use patent
patent.txt line 8,550
Flags
use code U-1
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,213,400, use patent
patent.txt line 14,346
Flags
use code U-2499
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,864,181, use patent
patent.txt line 14,349
Flags
use code U-3017
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 14,351
Flags
use code U-3323
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,253,494, use patent
patent.txt line 14,352
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,986,446, use patent
patent.txt line 14,355
Flags
use code U-3017
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,986,446, use patent
patent.txt line 14,356
Flags
use code U-3324
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,772,306, use patent
patent.txt line 14,361
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,772,306, use patent
patent.txt line 14,362
Flags
use code U-3198
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,050,302, use patent
patent.txt line 14,365
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,486,426, use patent
patent.txt line 14,368
Flags
use code U-1532
Product numbers
001
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 10,933,120, product patent
patent.txt lines 14,581, 14,596, 14,611
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 11,759,501, product patent
patent.txt lines 14,585, 14,600, 14,615
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 11,759,502, product patent
patent.txt lines 14,586, 14,601, 14,616
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 11,759,503, product patent
patent.txt lines 14,587, 14,602, 14,617
Flags
product
Product numbers
001, 002, 003
15 Mar 2033 · NDA 213051 · SEMAGLUTIDE
US 12,594,326, product patent
patent.txt lines 14,590, 14,605, 14,620
Flags
product
Product numbers
001, 002, 003
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 10,363,224, use patent
patent.txt lines 5,237, 5,242, 5,247, 5,252, 5,257
Flags
use code U-766
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 8,652,527, product patent
patent.txt lines 5,238, 5,243, 5,248, 5,253, 5,258
Flags
product
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 8,889,190, product patent
patent.txt lines 5,239, 5,244, 5,249, 5,254, 5,259
Flags
product
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 9,101,545, product patent
patent.txt lines 5,240, 5,245, 5,250, 5,255, 5,260
Flags
product
Product numbers
001, 002, 003, 004, 005
19 Mar 2033 · NDA 205122 · TOPIRAMATE
US 9,555,005, product patent
patent.txt lines 5,241, 5,246, 5,251, 5,256, 5,261
Flags
product
Product numbers
001, 002, 003, 004, 005
25 Mar 2033 · NDA 212099 · DAROLUTAMIDE
US 8,975,254, substance and product and use patent
patent.txt line 13,543
Flags
substance product use code U-4208
Product numbers
001
25 Mar 2033 · NDA 212099 · DAROLUTAMIDE
US 8,975,254, substance and product and use patent
patent.txt line 13,544
Flags
substance product use code U-4209
Product numbers
001
25 Mar 2033 · NDA 212099 · DAROLUTAMIDE
US 8,975,254, substance and product and use patent
patent.txt line 13,545
Flags
substance product use code U-4210
Product numbers
001
31 Mar 2033 · NDA 207233 · MELOXICAM
US 9,526,734, product patent
patent.txt lines 7,224, 7,228
Flags
product
Product numbers
001, 002
7 Apr 2033 · NDA 205677 · TASIMELTEON
US 11,918,556, use patent
patent.txt line 5,793
Flags
use code U-3342
Product numbers
001
7 Apr 2033 · NDA 205677 · TASIMELTEON
US 11,918,556, use patent
patent.txt line 5,794
Flags
use code U-3343
Product numbers
001
7 Apr 2033 · NDA 214517 · TASIMELTEON
US 11,918,556, use patent
patent.txt line 15,855
Flags
use code U-3342
Product numbers
001
12 Apr 2033 · NDA 212018 · ERDAFITINIB
US 8,895,601, substance and product patent
patent.txt lines 13,397, 13,415, 13,433
Flags
substance product
Product numbers
001, 002, 003
12 Apr 2033 · NDA 216196 · MITAPIVAT SULFATE
US 11,793,806, use patent
patent.txt lines 18,435, 18,444, 18,453
Flags
use code U-3320
Product numbers
001, 002, 003
22 Apr 2033 · NDA 204629 · EMPAGLIFLOZIN
US 12,527,810, use patent
patent.txt lines 4,898, 4,929
Flags
use code U-4403
Product numbers
001, 002
22 Apr 2033 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,527,810, use patent
patent.txt lines 6,313, 6,344, 6,373, 6,402
Flags
use code U-4403
Product numbers
001, 002, 003, 004
30 Apr 2033 · NDA 212295 · REMIMAZOLAM BESYLATE
US 9,561,236, use patent
patent.txt line 13,804
Flags
use code U-2968
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,441, use patent
patent.txt line 13,552
Flags
use code U-2860
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,442, use patent
patent.txt line 13,554
Flags
use code U-2860
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 12,097,206, use patent
patent.txt line 13,571
Flags
use code U-4013
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,549,909, use patent
patent.txt line 13,573
Flags
use code U-2858
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,814, use patent
patent.txt line 13,575
Flags
use code U-2858
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,815, use patent
patent.txt line 13,577
Flags
use code U-2858
Product numbers
001
3 May 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,610,260, use patent
patent.txt line 13,579
Flags
use code U-2858
Product numbers
001
15 May 2033 · NDA 202833 · INGENOL MEBUTATE
US 9,789,078, use patent
patent.txt line 3,386
Flags
use code U-2138
Product numbers
001
29 May 2033 · NDA 204569 · SUVOREXANT
US 10,098,892, product patent
patent.txt lines 4,826, 4,830, 4,834, 4,838
Flags
product
Product numbers
001, 002, 003, 004
29 May 2033 · NDA 204569 · SUVOREXANT
US 11,980,623, product patent
patent.txt lines 4,827, 4,831, 4,835, 4,839
Flags
product
Product numbers
001, 002, 003, 004
29 May 2033 · NDA 204569 · SUVOREXANT
US 12,599,610, product patent
patent.txt lines 4,828, 4,832, 4,836, 4,840
Flags
product
Product numbers
001, 002, 003, 004
30 May 2033 · NDA 211527 · TRIFAROTENE
US 9,084,778, product and use patent
patent.txt line 12,880
Flags
product use code U-134
Product numbers
001
30 May 2033 · NDA 211527 · TRIFAROTENE
US 9,498,465, product and use patent
patent.txt line 12,881
Flags
product use code U-1033
Product numbers
001
31 May 2033 · NDA 021695 · FENOFIBRATE
US 9,314,447, product and use patent
patent.txt line 681
Flags
product use code U-1447
Product numbers
005
31 May 2033 · NDA 021695 · FENOFIBRATE
US 9,314,447, product and use patent
patent.txt line 682
Flags
product use code U-1448
Product numbers
005
31 May 2033 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,300,054, product and use patent
patent.txt lines 14,884, 14,905, 14,926, 14,947
Flags
product use code U-3140
Product numbers
001, 002, 003, 004
31 May 2033 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,300,054, product and use patent
patent.txt lines 14,885, 14,906, 14,927, 14,948
Flags
product use code U-3141
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,106,548, substance and product patent
patent.txt lines 5,475, 5,574
Flags
substance product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,125,140, substance and product patent
patent.txt lines 5,477, 5,576
Flags
substance product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,294,231, product patent
patent.txt lines 5,479, 5,578
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,294,232, product patent
patent.txt lines 5,481, 5,580
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,752,634, product patent
patent.txt line 5,500
Flags
product
Product numbers
001
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 10,961,251, product patent
patent.txt lines 5,502, 5,599
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 9,713,617, product patent
patent.txt lines 5,554, 5,652
Flags
product
Product numbers
001, 002
3 Jun 2033 · NDA 205552 · IBRUTINIB
US 9,725,455, substance patent
patent.txt lines 5,556, 5,654
Flags
substance
Product numbers
001, 002
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,106,548, substance and product patent
patent.txt lines 11,597, 11,703, 11,807, 11,911
Flags
substance product
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,125,140, substance and product patent
patent.txt lines 11,599, 11,705, 11,809, 11,913
Flags
substance product
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,752,634, product patent
patent.txt line 11,620
Flags
product
Product numbers
001
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 10,961,251, product patent
patent.txt lines 11,624, 11,728, 11,832, 11,939
Flags
product
Product numbers
001, 002, 003, 004
3 Jun 2033 · NDA 210563 · IBRUTINIB
US 9,725,455, substance patent
patent.txt lines 11,682, 11,786, 11,890, 11,999
Flags
substance
Product numbers
001, 002, 003, 004
4 Jun 2033 · NDA 210951 · APALUTAMIDE
US 9,481,663, substance and product and use patent
patent.txt lines 12,445, 12,463
Flags
substance product use code U-2237
Product numbers
001, 002
4 Jun 2033 · NDA 210951 · APALUTAMIDE
US 9,481,663, substance and product and use patent
patent.txt lines 12,446, 12,464
Flags
substance product use code U-2624
Product numbers
001, 002
5 Jun 2033 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 10,403,170, use patent
patent.txt line 2,199
Flags
use code U-1583
Product numbers
001
5 Jun 2033 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 11,139,056, use patent
patent.txt line 2,203
Flags
use code U-1583
Product numbers
001
17 Jun 2033 · NDA 207999 · OBETICHOLIC ACID
US 10,174,073, substance patent
patent.txt lines 7,936, 7,943
Flags
substance
Product numbers
001, 002
17 Jun 2033 · NDA 207999 · OBETICHOLIC ACID
US 9,238,673, product patent
patent.txt lines 7,939, 7,946
Flags
product
Product numbers
001, 002
19 Jun 2033 · NDA 208183 · HALOBETASOL PROPIONATE
US 8,962,028, product and use patent
patent.txt line 8,296
Flags
product use code U-1775
Product numbers
001
19 Jun 2033 · NDA 213051 · SEMAGLUTIDE
US 11,033,499, product and use patent
patent.txt lines 14,583, 14,598, 14,613, 14,625, 14,634, 14,643
Flags
product use code U-2628
Product numbers
001, 002, 003, 004, 005, 006
19 Jun 2033 · NDA 218316 · SEMAGLUTIDE
US 11,033,499, product and use patent
patent.txt lines 20,934, 20,942, 20,950, 20,959
Flags
product use code U-4496
Product numbers
001, 002, 003, 004
21 Jun 2033 · NDA 209637 · SEMAGLUTIDE
US 10,335,462, use patent
patent.txt lines 10,687, 10,703
Flags
use code U-2580
Product numbers
001, 002
21 Jun 2033 · NDA 209637 · SEMAGLUTIDE
US 10,335,462, product and use patent
patent.txt line 10,738
Flags
product use code U-2580
Product numbers
004
21 Jun 2033 · NDA 209637 · SEMAGLUTIDE
US 10,335,462, use patent
patent.txt line 10,769
Flags
use code U-1852
Product numbers
007
21 Jun 2033 · NDA 215256 · SEMAGLUTIDE
US 9,764,003, use patent
patent.txt lines 16,610, 16,618, 16,626, 16,634, 16,644, 16,664, 16,676, 16,688, 16,700, 16,712, 16,717
Flags
use code U-3161
Product numbers
001, 002, 003, 004, 005, 007, 008, 009, 010, 011, 012
21 Jun 2033 · NDA 215256 · SEMAGLUTIDE
US 9,764,003, use patent
patent.txt line 16,652
Flags
use code U-4418
Product numbers
006
25 Jun 2033 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 9,633,575, use patent
patent.txt line 2,214
Flags
use code U-1583
Product numbers
001
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,278,935, use patent
patent.txt lines 2,622, 2,685
Flags
use code U-2701
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,278,936, use patent
patent.txt lines 2,623, 2,686
Flags
use code U-2702
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,278,937, use patent
patent.txt lines 2,624, 2,687
Flags
use code U-2703
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,383,840, use patent
patent.txt lines 2,625, 2,688
Flags
use code U-2704
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,555,924, use patent
patent.txt lines 2,626, 2,689
Flags
use code U-2743
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,555,925, use patent
patent.txt lines 2,627, 2,690
Flags
use code U-2744
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,568,861, use patent
patent.txt lines 2,628, 2,691
Flags
use code U-2756
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,576,054, use patent
patent.txt lines 2,629, 2,692
Flags
use code U-2762
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,668,042, use patent
patent.txt lines 2,630, 2,693
Flags
use code U-2841
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,786,478, use patent
patent.txt lines 2,631, 2,694
Flags
use code U-2959
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,786,478, use patent
patent.txt lines 2,632, 2,695
Flags
use code U-2960
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,792,270, use patent
patent.txt lines 2,634, 2,697
Flags
use code U-2962
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 10,894,028, use patent
patent.txt lines 2,638, 2,701
Flags
use code U-3053
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,000,499, use patent
patent.txt lines 2,639, 2,702
Flags
use code U-3126
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,116,742, use patent
patent.txt lines 2,641, 2,704
Flags
use code U-3221
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,298,333, use patent
patent.txt lines 2,644, 2,707
Flags
use code U-3358
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 11,369,582, use patent
patent.txt lines 2,645, 2,708
Flags
use code U-2841
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,603,826, use patent
patent.txt lines 2,675, 2,737
Flags
use code U-2696
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,610,272, use patent
patent.txt lines 2,676, 2,738
Flags
use code U-2697
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,623,001, use patent
patent.txt lines 2,677, 2,739
Flags
use code U-2698
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,693,984, use patent
patent.txt lines 2,678, 2,740
Flags
use code U-2697
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,693,985, use patent
patent.txt lines 2,679, 2,741
Flags
use code U-2696
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,693,986, use patent
patent.txt lines 2,680, 2,742
Flags
use code U-2698
Product numbers
001, 002
28 Jun 2033 · NDA 202057 · ICOSAPENT ETHYL
US 9,918,954, use patent
patent.txt lines 2,682, 2,744
Flags
use code U-2699
Product numbers
001, 002
1 Jul 2033 · NDA 208603 · MORPHINE SULFATE
US 9,044,402, product and use patent
patent.txt lines 8,902, 8,904, 8,906
Flags
product use code U-1556
Product numbers
001, 002, 003
1 Jul 2033 · NDA 208603 · MORPHINE SULFATE
US 9,549,899, product and use patent
patent.txt lines 8,903, 8,905, 8,907
Flags
product use code U-1556
Product numbers
001, 002, 003
9 Jul 2033 · NDA 208692 · CABOZANTINIB S-MALATE
US 9,724,342, product patent
patent.txt lines 9,196, 9,216, 9,236
Flags
product
Product numbers
001, 002, 003
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,028,946, use patent
patent.txt lines 3,422, 3,438, 3,454, 3,470, 3,486, 3,502
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,322,120, product patent
patent.txt lines 3,424, 3,440, 3,456, 3,472, 3,488, 3,504
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,456,393, use patent
patent.txt lines 3,425, 3,441, 3,457, 3,473, 3,489, 3,505
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,722,511, use patent
patent.txt lines 3,426, 3,442, 3,458, 3,474, 3,490, 3,506
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,265,760, use patent
patent.txt lines 3,428, 3,444, 3,460, 3,476, 3,492, 3,508
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,326,982, use patent
patent.txt lines 3,429, 3,445, 3,461, 3,477, 3,493, 3,509
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,333,201, use patent
patent.txt lines 3,430, 3,446, 3,462, 3,478, 3,494, 3,510
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,339,499, use patent
patent.txt lines 3,431, 3,447, 3,463, 3,479, 3,495, 3,511
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,421,200, use patent
patent.txt lines 3,432, 3,448, 3,464, 3,480, 3,496, 3,512
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,433,619, use patent
patent.txt lines 3,433, 3,449, 3,465, 3,481, 3,497, 3,513
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,610,286, use patent
patent.txt lines 3,436, 3,452, 3,468, 3,484, 3,500, 3,516
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 208073 · LIFITEGRAST
US 9,085,553, product patent
patent.txt line 8,090
Flags
product
Product numbers
001
5 Aug 2033 · NDA 210496 · ENCORAFENIB
US 9,474,754, use patent
patent.txt line 11,536
Flags
use code U-2802
Product numbers
002
5 Aug 2033 · NDA 210496 · ENCORAFENIB
US 9,474,754, use patent
patent.txt line 11,537
Flags
use code U-4051
Product numbers
002
5 Aug 2033 · NDA 210496 · ENCORAFENIB
US 9,474,754, use patent
patent.txt line 11,538
Flags
use code U-4440
Product numbers
002
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 10,857,143, product and use patent
patent.txt lines 7,836, 7,846, 7,856
Flags
product use code U-2993
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 11,103,494, product patent
patent.txt lines 7,837, 7,847, 7,857
Flags
product
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 11,103,495, product and use patent
patent.txt lines 7,838, 7,848, 7,858
Flags
product use code U-2993
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 11,633,389, product patent
patent.txt lines 7,839, 7,849, 7,859
Flags
product
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 8,999,386, product patent
patent.txt lines 7,842, 7,852, 7,862
Flags
product
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 9,295,642, product and use patent
patent.txt lines 7,843, 7,853, 7,863
Flags
product use code U-1827
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 9,545,399, product and use patent
patent.txt lines 7,844, 7,854, 7,864
Flags
product use code U-1827
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 9,844,544, product and use patent
patent.txt lines 7,845, 7,855, 7,865
Flags
product use code U-2203
Product numbers
001, 002, 003
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt line 3,346
Flags
product use code U-4345
Product numbers
001
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt lines 3,344, 3,358
Flags
product use code U-1515
Product numbers
001, 002
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt lines 3,345, 3,374
Flags
product use code U-1516
Product numbers
001, 003
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt line 3,375
Flags
product use code U-3644
Product numbers
003
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt line 3,376
Flags
product use code U-4566
Product numbers
003
16 Aug 2033 · NDA 211675 · UPADACITINIB
US RE47221, substance patent
patent.txt lines 13,024, 13,049, 13,068
Flags
substance
Product numbers
001, 002, 003
16 Aug 2033 · NDA 218347 · UPADACITINIB
US RE47221, substance patent
patent.txt line 20,979
Flags
substance
Product numbers
001
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt line 5,551
Flags
use code U-1684
Product numbers
001
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt lines 5,550, 5,649
Flags
use code U-1650
Product numbers
001, 002
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt lines 5,552, 5,650
Flags
use code U-1946
Product numbers
001, 002
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt line 5,648
Flags
use code U-1491
Product numbers
002
19 Aug 2033 · NDA 209500 · LUMATEPERONE TOSYLATE
US RE48839, use patent
patent.txt lines 10,467, 10,498, 10,528
Flags
use code U-3271
Product numbers
001, 002, 003
19 Aug 2033 · NDA 209500 · LUMATEPERONE TOSYLATE
US RE48839, use patent
patent.txt lines 10,468, 10,499, 10,529
Flags
use code U-4344
Product numbers
001, 002, 003
19 Aug 2033 · NDA 209500 · LUMATEPERONE TOSYLATE
US RE48839, use patent
patent.txt lines 10,469, 10,500, 10,530
Flags
use code U-814
Product numbers
001, 002, 003
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,525
Flags
substance product use code U-2350
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,526
Flags
substance product use code U-2533
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,527
Flags
substance product use code U-2534
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,528
Flags
substance product use code U-3213
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,529
Flags
substance product use code U-3386
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,530
Flags
substance product use code U-3742
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 8,927,607, use patent
patent.txt line 5,052
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,399,036, use patent
patent.txt line 5,053
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,555,029, use patent
patent.txt line 5,054
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,675,613, use patent
patent.txt line 5,055
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,789,108, use patent
patent.txt line 5,056
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 207620 · SACUBITRIL; VALSARTAN
US 11,135,192, use patent
patent.txt lines 7,376, 7,384, 7,392
Flags
use code U-3084
Product numbers
001, 002, 003
22 Aug 2033 · NDA 207620 · SACUBITRIL; VALSARTAN
US 9,517,226, use patent
patent.txt lines 7,381, 7,389, 7,397
Flags
use code U-3084
Product numbers
001, 002, 003
22 Aug 2033 · NDA 207620 · SACUBITRIL; VALSARTAN
US 9,937,143, use patent
patent.txt lines 7,382, 7,390, 7,398
Flags
use code U-3084
Product numbers
001, 002, 003
26 Aug 2033 · NDA 215341 · FINERENONE
US 8,436,180, substance and product patent
patent.txt lines 16,793, 16,795, 16,797
Flags
substance product
Product numbers
001, 002, 003
30 Aug 2033 · NDA 022535 · PIRFENIDONE
US 8,778,947, use patent
patent.txt line 2,075
Flags
use code U-1613
Product numbers
001
30 Aug 2033 · NDA 202806 · DABRAFENIB MESYLATE
US 10,869,869, use patent
patent.txt lines 3,251, 3,275
Flags
use code U-3185
Product numbers
001, 002
30 Aug 2033 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 10,869,869, use patent
patent.txt lines 4,272, 4,292, 4,312
Flags
use code U-3184
Product numbers
001, 002, 003
30 Aug 2033 · NDA 208780 · PIRFENIDONE
US 8,778,947, use patent
patent.txt lines 9,368, 9,411, 9,454
Flags
use code U-2044
Product numbers
001, 002, 003
30 Aug 2033 · NDA 208780 · PIRFENIDONE
US 8,778,947, use patent
patent.txt lines 9,369, 9,412, 9,455
Flags
use code U-2045
Product numbers
001, 002, 003
2 Sep 2033 · NDA 205858 · IDELALISIB
US 9,469,643, substance patent
patent.txt lines 5,990, 5,994
Flags
substance
Product numbers
001, 002
6 Sep 2033 · NDA 207999 · OBETICHOLIC ACID
US 10,047,117, use patent
patent.txt lines 7,934, 7,941
Flags
use code U-1854
Product numbers
001, 002
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 10,993,942, use patent
patent.txt lines 8,861, 8,875, 8,889
Flags
use code U-3114
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,110,087, use patent
patent.txt lines 8,862, 8,876, 8,890
Flags
use code U-3222
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,110,087, use patent
patent.txt lines 8,863, 8,877, 8,891
Flags
use code U-3223
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,413,282, use patent
patent.txt lines 8,865, 8,879, 8,893
Flags
use code U-3412
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,590,128, use patent
patent.txt lines 8,866, 8,880, 8,894
Flags
use code U-3548
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 9,539,251, use patent
patent.txt lines 8,873, 8,887, 8,901
Flags
use code U-2538
Product numbers
001, 002, 003
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 10,016,504, product patent
patent.txt line 10,276
Flags
product
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 10,918,723, use patent
patent.txt line 10,280
Flags
use code U-2310
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 12,083,179, product and use patent
patent.txt line 10,282
Flags
product use code U-2310
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 8,999,313, product patent
patent.txt line 10,283
Flags
product
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 9,326,969, use patent
patent.txt line 10,284
Flags
use code U-2310
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 9,707,297, product patent
patent.txt line 10,286
Flags
product
Product numbers
001
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 11,839,689, product patent
patent.txt lines 15,162, 15,177
Flags
product
Product numbers
001, 002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,447,128, use patent
patent.txt line 15,182
Flags
use code U-4312
Product numbers
002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,447,128, use patent
patent.txt line 15,183
Flags
use code U-4313
Product numbers
002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,447,128, use patent
patent.txt line 15,184
Flags
use code U-4314
Product numbers
002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,502,357, use patent
patent.txt lines 15,167, 15,185
Flags
use code U-4363
Product numbers
001, 002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,502,357, use patent
patent.txt lines 15,168, 15,186
Flags
use code U-4364
Product numbers
001, 002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,502,357, use patent
patent.txt lines 15,169, 15,187
Flags
use code U-4365
Product numbers
001, 002
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 11,666,566, product patent
patent.txt lines 8,126, 8,158, 8,190
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,233,959, product patent
patent.txt lines 8,135, 8,167, 8,199
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,296,739, product patent
patent.txt lines 8,137, 8,169, 8,201
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 8,139, 8,171, 8,203
Flags
substance product use code U-1995
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 8,140, 8,172, 8,204
Flags
substance product use code U-3055
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,814,708, product patent
patent.txt lines 8,142, 8,174, 8,206
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 216354 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 18,552, 18,582, 18,612, 18,642, 18,672, 18,702, 18,732, 18,762
Flags
substance product use code U-1995
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
18 Sep 2033 · NDA 216354 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 18,553, 18,583, 18,613, 18,643, 18,673, 18,703, 18,733, 18,763
Flags
substance product use code U-3055
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
20 Sep 2033 · NDA 211855 · DIROXIMEL FUMARATE
US 10,080,733, substance and product and use patent
patent.txt line 13,217
Flags
substance product use code U-1384
Product numbers
001
20 Sep 2033 · NDA 211855 · DIROXIMEL FUMARATE
US 9,090,558, use patent
patent.txt line 13,219
Flags
use code U-1384
Product numbers
001
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US 10,849,888, use patent
patent.txt lines 12,434, 12,452
Flags
use code U-3013
Product numbers
001, 002
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US 9,884,054, use patent
patent.txt lines 12,447, 12,465
Flags
use code U-2237
Product numbers
001, 002
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US RE49353, use patent
patent.txt lines 12,449, 12,467
Flags
use code U-2381
Product numbers
001, 002
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US RE50642, use patent
patent.txt lines 12,450, 12,468
Flags
use code U-4450
Product numbers
001, 002
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 10,980,803, use patent
patent.txt lines 3,523, 3,540, 3,557, 3,574
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 10,980,803, use patent
patent.txt lines 3,524, 3,541, 3,558, 3,575
Flags
use code U-543
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,154,553, use patent
patent.txt lines 3,525, 3,542, 3,559, 3,576
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,154,553, use patent
patent.txt lines 3,526, 3,543, 3,560, 3,577
Flags
use code U-3245
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,154,553, use patent
patent.txt lines 3,527, 3,544, 3,561, 3,578
Flags
use code U-814
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,344,547, use patent
patent.txt lines 3,528, 3,545, 3,562, 3,579
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,344,547, use patent
patent.txt lines 3,529, 3,546, 3,563, 3,580
Flags
use code U-3245
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,344,547, use patent
patent.txt lines 3,530, 3,547, 3,564, 3,581
Flags
use code U-814
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,400,087, use patent
patent.txt lines 3,531, 3,548, 3,565, 3,582
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,400,087, use patent
patent.txt lines 3,532, 3,549, 3,566, 3,583
Flags
use code U-3245
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,400,087, use patent
patent.txt lines 3,533, 3,550, 3,567, 3,584
Flags
use code U-814
Product numbers
001, 002, 003, 004
27 Sep 2033 · NDA 214621 · RELUGOLIX
US 11,795,178, substance and product patent
patent.txt line 15,884
Flags
substance product
Product numbers
001
27 Sep 2033 · NDA 214621 · RELUGOLIX
US 12,325,714, substance and product patent
patent.txt line 15,887
Flags
substance product
Product numbers
001
27 Sep 2033 · NDA 214846 · ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US 11,795,178, substance and product patent
patent.txt line 16,238
Flags
substance product
Product numbers
001
27 Sep 2033 · NDA 214846 · ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US 12,325,714, substance and product patent
patent.txt line 16,240
Flags
substance product
Product numbers
001
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,183,931, use patent
patent.txt line 16,114
Flags
use code U-3246
Product numbers
001
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,183,931, use patent
patent.txt line 16,115
Flags
use code U-4260
Product numbers
001
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,696,660, use patent
patent.txt line 16,116
Flags
use code U-3246
Product numbers
001
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,696,660, use patent
patent.txt line 16,117
Flags
use code U-4260
Product numbers
001
8 Oct 2033 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 11,123,363, use patent
patent.txt lines 5,824, 5,831, 5,838, 5,845
Flags
use code U-1766
Product numbers
001, 002, 003, 004
8 Oct 2033 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 9,492,476, use patent
patent.txt lines 5,829, 5,836, 5,843, 5,850
Flags
use code U-1766
Product numbers
001, 002, 003, 004
8 Oct 2033 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 9,925,212, use patent
patent.txt lines 5,830, 5,837, 5,844, 5,851
Flags
use code U-1766
Product numbers
001, 002, 003, 004
18 Oct 2033 · NDA 210498 · BINIMETINIB
US 9,562,016, substance and product patent
patent.txt line 11,555
Flags
substance product
Product numbers
001
18 Oct 2033 · NDA 210498 · BINIMETINIB
US 9,598,376, use patent
patent.txt line 11,556
Flags
use code U-2330
Product numbers
001
18 Oct 2033 · NDA 210498 · BINIMETINIB
US 9,980,944, use patent
patent.txt line 11,558
Flags
use code U-2334
Product numbers
001
22 Oct 2033 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 10,695,365, substance patent
patent.txt lines 7,013, 7,026
Flags
substance
Product numbers
001, 002
22 Oct 2033 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 8,877,255, substance patent
patent.txt lines 7,018, 7,031
Flags
substance
Product numbers
001, 002
22 Oct 2033 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 9,913,860, substance and use patent
patent.txt lines 7,022, 7,035
Flags
substance use code U-2312
Product numbers
001, 002
23 Oct 2033 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,066,856, product patent
patent.txt line 5,289
Flags
product
Product numbers
001
23 Oct 2033 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,486,406, product patent
patent.txt line 5,291
Flags
product
Product numbers
001
23 Oct 2033 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,855,246, product patent
patent.txt line 5,292
Flags
product
Product numbers
001
29 Oct 2033 · NDA 211855 · DIROXIMEL FUMARATE
US 8,669,281, substance and product patent
patent.txt line 13,218
Flags
substance product
Product numbers
001
30 Oct 2033 · NDA 205552 · IBRUTINIB
US 9,296,753, substance and product patent
patent.txt line 5,548
Flags
substance product
Product numbers
001
30 Oct 2033 · NDA 205552 · IBRUTINIB
US 9,296,753, substance patent
patent.txt line 5,646
Flags
substance
Product numbers
002
30 Oct 2033 · NDA 210563 · IBRUTINIB
US 9,296,753, substance patent
patent.txt lines 11,678, 11,782, 11,886, 11,995
Flags
substance
Product numbers
001, 002, 003, 004
11 Nov 2033 · NDA 203168 · BROMFENAC SODIUM
US 9,517,220, use patent
patent.txt line 3,650
Flags
use code U-1933
Product numbers
001
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 10,874,616, product patent
patent.txt lines 19,293, 19,346, 19,399, 19,452, 19,505
Flags
product
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,302, 19,355, 19,408, 19,461, 19,514
Flags
use code U-3226
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,303, 19,356, 19,409, 19,462, 19,515
Flags
use code U-3227
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,304, 19,357, 19,410, 19,463, 19,516
Flags
use code U-3228
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,305, 19,358, 19,411, 19,464, 19,517
Flags
use code U-3230
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,307, 19,360, 19,413, 19,466, 19,519
Flags
product use code U-3226
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,308, 19,361, 19,414, 19,467, 19,520
Flags
product use code U-3227
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,309, 19,362, 19,415, 19,468, 19,521
Flags
product use code U-3228
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,310, 19,363, 19,416, 19,469, 19,522
Flags
product use code U-3230
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,314, 19,367, 19,420, 19,473, 19,526
Flags
product use code U-3226
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,315, 19,368, 19,421, 19,474, 19,527
Flags
product use code U-3227
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,316, 19,369, 19,422, 19,475, 19,528
Flags
product use code U-3228
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,317, 19,370, 19,423, 19,476, 19,529
Flags
product use code U-3230
Product numbers
001, 002, 003, 004, 005
18 Nov 2033 · NDA 207154 · DAPSONE
US 11,273,132, product patent
patent.txt line 7,054
Flags
product
Product numbers
001
25 Nov 2033 · NDA 213137 · VOXELOTOR
US 9,018,210, substance and product patent
patent.txt lines 14,675, 14,688
Flags
substance product
Product numbers
001, 002
25 Nov 2033 · NDA 216157 · VOXELOTOR
US 9,018,210, substance and product patent
patent.txt line 18,373
Flags
substance product
Product numbers
001
30 Nov 2033 · NDA 205437 · APREMILAST
US 12,576,034, product and use patent
patent.txt lines 5,401, 5,413, 5,425
Flags
product use code U-1858
Product numbers
001, 002, 003
30 Nov 2033 · NDA 205437 · APREMILAST
US 12,576,034, product and use patent
patent.txt lines 5,402, 5,414, 5,426
Flags
product use code U-4290
Product numbers
001, 002, 003
30 Nov 2033 · NDA 205437 · APREMILAST
US 12,576,034, product and use patent
patent.txt lines 5,403, 5,415, 5,427
Flags
product use code U-4291
Product numbers
001, 002, 003
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,895, use patent
patent.txt lines 3,875, 3,892, 3,909, 3,926
Flags
use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,895, use patent
patent.txt lines 3,876, 3,893, 3,910, 3,927
Flags
use code U-1701
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,895, use patent
patent.txt lines 3,877, 3,894, 3,911, 3,928
Flags
use code U-1948
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,897, substance and use patent
patent.txt lines 3,878, 3,895, 3,912, 3,929
Flags
substance use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,897, substance and use patent
patent.txt lines 3,879, 3,896, 3,913, 3,930
Flags
substance use code U-1701
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,897, substance and use patent
patent.txt lines 3,880, 3,897, 3,914, 3,931
Flags
substance use code U-1948
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,384,086, substance and product and use patent
patent.txt lines 3,881, 3,898, 3,915, 3,932
Flags
substance product use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,384,086, substance and product and use patent
patent.txt lines 3,882, 3,899, 3,916, 3,933
Flags
substance product use code U-1701
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,384,086, substance and product and use patent
patent.txt lines 3,883, 3,900, 3,917, 3,934
Flags
substance product use code U-1948
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 9,493,470, substance and product and use patent
patent.txt lines 3,890, 3,907, 3,924, 3,941
Flags
substance product use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 9,493,470, substance and product and use patent
patent.txt lines 3,891, 3,908, 3,925, 3,942
Flags
substance product use code U-1948
Product numbers
001, 002, 003, 004
18 Dec 2033 · NDA 208073 · LIFITEGRAST
US 11,058,677, product patent
patent.txt line 8,083
Flags
product
Product numbers
001
19 Dec 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,216,996, substance and product patent
patent.txt lines 11,217, 11,226
Flags
substance product
Product numbers
001, 002
19 Dec 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,732,092, substance and product patent
patent.txt lines 11,221, 11,230
Flags
substance product
Product numbers
001, 002
23 Dec 2033 · NDA 211765 · UBROGEPANT
US 8,912,210, substance and product patent
patent.txt lines 13,168, 13,180
Flags
substance product
Product numbers
001, 002

Pediatric exclusivity, as listed (58)

9 Jan 2033 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 9,254,286 with pediatric exclusivity, as listed
patent.txt line 9,239
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt line 7,356
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt line 7,360
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt lines 8,335, 8,344
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Feb 2033 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt lines 8,339, 8,346
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Feb 2033 · NDA 208351 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt line 8,543
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208351 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt line 8,545
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt line 8,659
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt line 8,663
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Feb 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065 with pediatric exclusivity, as listed
patent.txt lines 11,215, 11,224
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Feb 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769 with pediatric exclusivity, as listed
patent.txt lines 11,218, 11,227
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
6 Apr 2033 · NDA 203094 · COBICISTAT
US 10,039,718 with pediatric exclusivity, as listed
patent.txt lines 3,621, 3,625
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
6 Apr 2033 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 10,039,718 with pediatric exclusivity, as listed
patent.txt line 3,629
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
6 Apr 2033 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 10,039,718 with pediatric exclusivity, as listed
patent.txt line 7,346
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
12 Apr 2033 · NDA 205422 · BREXPIPRAZOLE
US 10,307,419 with pediatric exclusivity, as listed
patent.txt lines 5,307, 5,320, 5,333, 5,346, 5,359
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
1 May 2033 · NDA 205065 · SAPROPTERIN DIHYDROCHLORIDE
US 9,216,178 with pediatric exclusivity, as listed
patent.txt lines 5,197, 5,199
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
18 May 2033 · NDA 214787 · REMDESIVIR
US 10,065,958 with pediatric exclusivity, as listed
patent.txt lines 16,121, 16,160
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
27 Aug 2033 · NDA 202714 · CARFILZOMIB
US 9,493,582 with pediatric exclusivity, as listed
patent.txt lines 3,142, 3,152, 3,162
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 10,272,046 with pediatric exclusivity, as listed
patent.txt lines 7,491, 7,524, 7,557, 7,590, 7,618
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 11,147,770 with pediatric exclusivity, as listed
patent.txt lines 7,495, 7,528, 7,561, 7,594, 7,622
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 11,752,106 with pediatric exclusivity, as listed
patent.txt lines 7,499, 7,532, 7,565, 7,598, 7,626
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 12,214,083 with pediatric exclusivity, as listed
patent.txt lines 7,501, 7,534, 7,567, 7,600, 7,628
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 8,883,206 with pediatric exclusivity, as listed
patent.txt lines 7,519, 7,552, 7,585, 7,614, 7,642
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
6 Sep 2033 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,555,001 with pediatric exclusivity, as listed
patent.txt lines 7,988, 8,007
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 10,213,400 with pediatric exclusivity, as listed
patent.txt line 489
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 10,864,181 with pediatric exclusivity, as listed
patent.txt line 491
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 11,253,494 with pediatric exclusivity, as listed
patent.txt line 493
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 8,772,306 with pediatric exclusivity, as listed
patent.txt line 497
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 9,050,302 with pediatric exclusivity, as listed
patent.txt line 499
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 9,486,426 with pediatric exclusivity, as listed
patent.txt line 501
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,213,400 with pediatric exclusivity, as listed
patent.txt line 14,345
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,864,181 with pediatric exclusivity, as listed
patent.txt line 14,348
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,253,494 with pediatric exclusivity, as listed
patent.txt line 14,350
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,772,306 with pediatric exclusivity, as listed
patent.txt line 14,360
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,050,302 with pediatric exclusivity, as listed
patent.txt line 14,364
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,486,426 with pediatric exclusivity, as listed
patent.txt line 14,367
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
22 Oct 2033 · NDA 204629 · EMPAGLIFLOZIN
US 12,527,810 with pediatric exclusivity, as listed
patent.txt lines 4,897, 4,928
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
22 Oct 2033 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,527,810 with pediatric exclusivity, as listed
patent.txt lines 6,312, 6,343, 6,372, 6,401
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,441 with pediatric exclusivity, as listed
patent.txt line 13,551
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,442 with pediatric exclusivity, as listed
patent.txt line 13,553
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 12,097,206 with pediatric exclusivity, as listed
patent.txt line 13,570
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,549,909 with pediatric exclusivity, as listed
patent.txt line 13,572
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,814 with pediatric exclusivity, as listed
patent.txt line 13,574
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,815 with pediatric exclusivity, as listed
patent.txt line 13,576
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,610,260 with pediatric exclusivity, as listed
patent.txt line 13,578
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,106,548 with pediatric exclusivity, as listed
patent.txt lines 5,474, 5,573
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,125,140 with pediatric exclusivity, as listed
patent.txt lines 5,476, 5,575
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,294,231 with pediatric exclusivity, as listed
patent.txt lines 5,478, 5,577
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,294,232 with pediatric exclusivity, as listed
patent.txt lines 5,480, 5,579
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,752,634 with pediatric exclusivity, as listed
patent.txt line 5,499
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,961,251 with pediatric exclusivity, as listed
patent.txt lines 5,501, 5,598
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 9,713,617 with pediatric exclusivity, as listed
patent.txt lines 5,553, 5,651
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 9,725,455 with pediatric exclusivity, as listed
patent.txt lines 5,555, 5,653
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,106,548 with pediatric exclusivity, as listed
patent.txt lines 11,596, 11,702, 11,806, 11,910
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,125,140 with pediatric exclusivity, as listed
patent.txt lines 11,598, 11,704, 11,808, 11,912
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,752,634 with pediatric exclusivity, as listed
patent.txt line 11,619
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,961,251 with pediatric exclusivity, as listed
patent.txt lines 11,623, 11,727, 11,831, 11,938
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 9,725,455 with pediatric exclusivity, as listed
patent.txt lines 11,681, 11,785, 11,889, 11,998
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004

Non-patent exclusivity (2)

12 Feb 2033 · NDA 214012 · INCLISIRAN SODIUM
ODE-555 exclusivity
exclusivity.txt line 1,291
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
13 Feb 2033 · NDA 211150 · PITOLISANT HYDROCHLORIDE
ODE-519 exclusivity
exclusivity.txt lines 936, 941
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002